IJEOMA AJUFO: Open Payments
NPI 1902216427 · SAN ANTONIO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$359 in 16 payments from 4 companies in 2025. Trend: 2023 $399 · 2024 $504 · 2025 $359
Food & beverage: $359
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 10 | $240 |
| Supernus Pharmaceuticals, Inc. | 3 | $54 |
| Janssen Pharmaceuticals, Inc | 2 | $50 |
| E.R. Squibb & Sons, L.L.C. | 1 | $15 |
Products named: CAPLYTA, Qelbree, SPRAVATO, COBENFY.
Industry payments across TX — which companies pay providers there.
